Prime Medicine
PRME
PRME
122 hedge funds and large institutions have $354M invested in Prime Medicine in 2024 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
122
Holders Change
+7
Holders Change %
+6.09%
% of All Funds
1.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
26
Increased
45
Reduced
31
Closed
19
Calls
$772K
Puts
$275K
Net Calls
+$497K
Net Calls Change
+$579K
Top Buyers
| 1 |
BlackRock
New York
|
+$6.96M |
| 2 |
Millennium Management
New York
|
+$4.6M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$3.27M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.26M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.95M |
Top Sellers
| 1 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$6.66M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$5.02M |
| 3 |
Renaissance Technologies
New York
|
-$2.54M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$2.31M |
| 5 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$2.13M |
